Evidence map›Paper›PMID 38706740›Full record

ReviewMedComm2024

RNA modifications in pulmonary diseases.

Weiwei Qian, Lvying Yang, Tianlong Li, Wanlin Li, Jian Zhou, Shenglong Xie

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in MedComm, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weiwei QianEmergency Department of Emergency Medicine Laboratory of Emergency Medicine, West China Hospital, And Disaster Medical, Sichuan University Chengdu Sichuan China.ORCID https://orcid.org/0009-0003-2074-8702
Lvying YangThe Department of Respiratory and Critical Care Medicine The First Veterans Hospital of Sichuan Province Chengdu Sichuan China.
Tianlong LiDepartment of Critical Care Medicine Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu Sichuan China.
Wanlin LiNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital Shenzhen Guangdong China.
Jian ZhouGuangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School Shenzhen China.
Shenglong XieDepartment of Thoracic Surgery Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China Chengdu Sichuan China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Threatening public health, pulmonary disease (PD) encompasses diverse lung injuries like chronic obstructive PD, pulmonary fibrosis, asthma, pulmonary infections due to pathogen invasion, and fatal lung cancer. The crucial involvement of RNA epigenetic modifications in PD pathogenesis is underscored by robust evidence. These modifications not only shape cell fates but also finely modulate the expression of genes linked to disease progression, suggesting their utility as biomarkers and targets for therapeutic strategies. The critical RNA modifications implicated in PDs are summarized in this review, including N

Indexed as

functions of RNA modificationspulmonary diseasesRNA modification databaseRNA modifications

Identifiers

PMID38706740
PMCPMC11068158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.